Allan Jonathan

CIK 00019667161 companyBEDFORD, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001966716

Recent Transactions

50 trades

Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-08$31.60/sh−1,300→ 14,509 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-08$32.61/sh−2,678→ 11,831 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.76/sh−2,344→ 15,809 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.33/sh−1,004→ 23,590 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-05$31.08/sh−5,437→ 18,153 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-04$30.76/sh−824→ 24,788 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-04$31.32/sh−194→ 24,594 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03$30.85/sh−1,394→ 19,612 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03$30.34/sh−898→ 21,006 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-03+6,000→ 25,612 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Performance Stock Units
2025-12-03−6,000→ 0 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-02$29.56/sh−1,416→ 22,772 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-02$30.14/sh−868→ 21,904 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2025-12-01−12,357→ 0 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-12-01+12,357→ 24,188 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-10-03$25.07/sh−10,000→ 11,831 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Stock Option (Right to Buy)
2025-10-03−10,000→ 34,800 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-10-03$9.15/sh+10,000→ 21,831 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-09-03$20.07/sh−6,345→ 11,831 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-09-02$20.14/sh−14,922→ 18,176 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Stock Option (Right to Buy)
2025-09-02−9,150→ 15,801 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-09-02$7.07/sh+9,150→ 33,098 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-08-29$20.00/sh−850→ 23,948 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-08-29$7.07/sh+850→ 24,798 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Stock Option (Right to Buy)
2025-08-29−850→ 24,951 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-08-18$18.24/sh−1,683→ 23,948 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Performance Stock Units
2025-08-14−6,000→ 6,000 total
Award
Stoke Therapeutics, Inc.$STOK
Performance Stock Units
2025-08-14+12,000→ 12,000 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-08-14+6,000→ 25,631 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-08-13$15.00/sh−13,712→ 19,631 total
Award
Stoke Therapeutics, Inc.$STOK
Employee Stock Option (Right to Buy)
2025-03-20+72,000→ 72,000 total
Award
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2025-03-20+48,000→ 48,000 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-03-19$8.27/sh−1,945→ 31,565 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-03-18$8.67/sh−2,266→ 33,510 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-03-15+7,475→ 29,776 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2025-03-15−6,000→ 18,000 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Units
2025-03-15−7,475→ 14,950 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2025-03-15+6,000→ 35,776 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-12-09$13.69/sh−12,114→ 23,028 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-12-09$12.99/sh−1,552→ 21,476 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-12-06$12.78/sh−9,696→ 35,142 total
Award
Stoke Therapeutics, Inc.$STOK
Performance Stock Units
2024-12-03+12,000→ 12,000 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-12-03+6,000→ 44,838 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Performance Stock Units
2024-12-03−6,000→ 6,000 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-12-01+33,927→ 38,838 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Restricted Stock Unit (RSU)
2024-12-01−33,927→ 12,357 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-05-20$7.07/sh+8,599→ 11,197 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-05-20$15.04/sh−8,599→ 2,598 total
Exercise/Conversion
Stoke Therapeutics, Inc.$STOK
Stock Option (Right to Buy)
2024-05-20−8,599→ 25,801 total
Sale
Stoke Therapeutics, Inc.$STOK
Common Stock
2024-03-28$13.19/sh−5,026→ 2,698 total

Companies

Stoke Therapeutics, Inc.
GENERAL COUNSEL & CORP SEC
$STOK

Recent Filings

Address

C/O STOKE THERAPEUTICS, INC. 45 WIGGINS AVENUE

BEDFORD, MA, 01730

View on SEC.gov